Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab (Q43055328)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 May 2010
edit
Language Label Description Also known as
English
Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab
scientific article published on 24 May 2010

    Statements

    Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab (English)
    Sharon Barrans
    Simon Crouch
    Alex Smith
    Kathryn Turner
    Roger Owen
    Russell Patmore
    Eve Roman
    Andrew Jack
    24 May 2010
    3360-3365

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit